Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu hodnotící studie, časopisecké články, práce podpořená grantem, přehledy
- MeSH
- houby genetika izolace a purifikace MeSH
- klinické laboratorní techniky metody MeSH
- lidé MeSH
- mykózy diagnóza mikrobiologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Although invasive fungal diseases (IFDs) are relatively rare, they have become an increasingly common life-threatening complication in a variety of critically ill patients. Due to changes in treatment strategies, patterns of IFDs have changed substantially as well. Yeast infections have shifted toward a higher proportion of non-albicans Candida species, but their overall incidence has remained stable. In contrast, IFDs caused by molds, including particularly various species of Aspergillus, Fusarium, and Mucorales, have increased in number. In view of the growing incidence and the high mortality rates of IFDs, accurate diagnostic techniques permitting timely onset of adequate antifungal treatment are of paramount importance. Although conventional approaches such as microscopy, cultivation, histopathological examination, and imaging methods still represent the gold standard, the diagnosis remains difficult because of limited sensitivity and specificity. Noninvasive and culture-independent diagnostic techniques, including fungal antigen detection, and different molecular-based techniques are becoming increasingly important. Of the fungal surrogate markers such as cell wall components, galactomannan and (1,3)-β-D-glucan by commercially available diagnostic kits have become widely used, but the results are still controversial. A plethora of PCR-based diagnostic methods targeting different gene regions and exploiting a variety of amplicon detection tools have been published. Molecular assays have the capacity to overcome the limitations of other diagnostic approaches, but the current lack of methodological standardization and validation, together with not always clear interpretation of the results, has prevented broad application in the clinical setting.
Zobrazit více v PubMed
Clin Infect Dis. 2005 Sep 1;41(5):654-9 PubMed
Bone Marrow Transplant. 2006 May;37(9):857-64 PubMed
Curr Opin Oncol. 2010 Mar;22(2):138-42 PubMed
J Clin Microbiol. 2005 Jan;43(1):299-305 PubMed
J Clin Oncol. 2009 Jul 10;27(20):3398-409 PubMed
Bone Marrow Transplant. 2005 Feb;35(3):303-6 PubMed
Exp Dermatol. 2009 Oct;18(10):880-2 PubMed
N Engl J Med. 1991 Apr 11;324(15):1026-31 PubMed
Clin Vaccine Immunol. 2008 Jul;15(7):1132-3 PubMed
Drug Resist Updat. 2010 Dec;13(6):180-95 PubMed
Med Mycol. 2011 Jan;49(1):73-9 PubMed
Cancer. 2009 Jan 15;115(2):355-62 PubMed
Clin Infect Dis. 2004 Jul 15;39(2):199-205 PubMed
Lancet. 2003 Nov 29;362(9398):1828-38 PubMed
Expert Rev Mol Diagn. 2009 Jul;9(5):397-401 PubMed
Med Mycol. 2006 Dec;44(8):733-9 PubMed
Curr Infect Dis Rep. 2007 Nov;9(6):465-71 PubMed
Cancer. 2002 Feb 15;94(4):1032-6 PubMed
J Clin Microbiol. 2006 Nov;44(11):3894-9 PubMed
J Clin Microbiol. 1999 Dec;37(12):3865-71 PubMed
BMC Infect Dis. 2007 Sep 04;7:103 PubMed
Med Mycol. 2009;47 Suppl 1:S282-90 PubMed
J Microbiol Immunol Infect. 2007 Apr;40(2):148-53 PubMed
Am J Med. 2012 Jan;125(1 Suppl):S14-24 PubMed
Med Mycol. 2011 Nov;49(8):856-63 PubMed
J Med Microbiol. 2007 Sep;56(Pt 9):1167-1173 PubMed
Clin Microbiol Infect. 2011 Apr;17(4):546-51 PubMed
Clin Microbiol Infect. 2008 May;14 Suppl 4:5-24 PubMed
Mycoses. 2010 Jan;53(1):1-11 PubMed
Microbiol Immunol. 1993;37(3):207-12 PubMed
Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):613-22 PubMed
Future Microbiol. 2010 Nov;5(11):1733-54 PubMed
Pediatr Rep. 2011 Jun 16;3(2):e14 PubMed
Mycoses. 2009 May;52(3):197-205 PubMed
J Infect Dis. 2002 Apr 15;185(8):1203-6 PubMed
Am J Clin Pathol. 2004 Jan;121(1):18-25 PubMed
J Clin Microbiol. 1997 Sep;35(9):2206-9 PubMed
Lancet Infect Dis. 2009 Feb;9(2):89-96 PubMed
Clin Microbiol Rev. 2002 Jul;15(3):465-84 PubMed
BMC Infect Dis. 2011 Mar 09;11:60 PubMed
Infect Dis Clin North Am. 2010 Jun;24(2):439-59 PubMed
Intern Med. 2011;50(22):2783-91 PubMed
Clin Infect Dis. 2008 Feb 1;46(3):327-60 PubMed
J Clin Microbiol. 2007 Mar;45(3):906-14 PubMed
Rev Iberoam Micol. 2006 Dec;23(4):209-15 PubMed
Crit Care Med. 2010 Aug;38(8 Suppl):S380-7 PubMed
Leukemia. 2010 Dec;24(12):2032-8 PubMed
J Clin Microbiol. 1994 Jan;32(1):228-31 PubMed
Med Mycol. 1998 Oct;36(5):275-9 PubMed
J Mol Diagn. 2006 Jul;8(3):376-84 PubMed
Clin Infect Dis. 2007 May 15;44(10):1329-36 PubMed
Clin Microbiol Infect. 2012 May;18(5):475-84 PubMed
Minerva Ginecol. 2007 Jun;59(3):311-29 PubMed
Clin Infect Dis. 2008 Jun 15;46(12):1930-1 PubMed
Immunol Lett. 2007 Mar 15;109(1):76-82 PubMed
J Clin Microbiol. 2008 Jun;46(6):1919-26 PubMed
Clin Infect Dis. 2009 Dec 1;49(11):1650-9 PubMed
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD007394 PubMed
Clin Infect Dis. 2004 Mar 15;38(6):913-6 PubMed
Hum Immunol. 2007 Jan;68(1):41-50 PubMed
Med Mycol. 2007 Mar;45(2):97-121 PubMed
Clin Microbiol Infect. 2011 Dec;17(12):E27-9 PubMed
Clin Infect Dis. 2012 Mar 1;54(5):633-43 PubMed
J Clin Oncol. 2002 Apr 1;20(7):1898-906 PubMed
Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5 PubMed
J Infect Dis. 2006 Mar 1;193(5):741-7 PubMed
Diagn Microbiol Infect Dis. 2005 Feb;51(2):95-101 PubMed
J Clin Microbiol. 2005 Nov;43(11):5828-9 PubMed
J Clin Microbiol. 2010 Mar;48(3):900-7 PubMed
J Clin Microbiol. 2005 Dec;43(12):5957-62 PubMed
Clin Microbiol Infect. 2008 May;14 Suppl 4:37-45 PubMed
Clin Infect Dis. 2001 May 1;32(9):1319-24 PubMed
J Clin Microbiol. 2007 Nov;45(11):3743-53 PubMed
Diagn Microbiol Infect Dis. 2011 Jul;70(3):330-43 PubMed
Clin Microbiol Infect. 2009 Jul;15(7):625-33 PubMed
Eur J Med Res. 2002 May 31;7(5):236-41 PubMed
Transpl Infect Dis. 2002;4 Suppl 3:32-7 PubMed
J Clin Microbiol. 2007 Sep;45(9):3141-2 PubMed
Antimicrob Agents Chemother. 2006 Oct;50(10):3450-3 PubMed
Infect Dis Clin North Am. 2006 Sep;20(3):711-27, viii PubMed
J Clin Microbiol. 2005 Oct;43(10):5122-8 PubMed
J Clin Microbiol. 2006 Mar;44(3):693-9 PubMed
Am J Infect Control. 2007 Apr;35(3):183-9 PubMed
J Clin Microbiol. 1996 Aug;34(8):1918-21 PubMed
N Engl J Med. 2008 Oct 23;359(17):1766-77 PubMed
Am J Med. 1995 Aug;99(2):164-72 PubMed
Clin Microbiol Infect. 2012 Nov;18(11):1117-25 PubMed
Am J Med. 2012 Jan;125(1 Suppl):S3-13 PubMed
J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i15-24 PubMed
Pediatr Infect Dis J. 2009 Aug;28(8):734-7 PubMed
J Clin Microbiol. 2010 Oct;48(10):3648-53 PubMed
Clin Infect Dis. 2008 Jun 15;46(12):1864-70 PubMed
J Clin Pathol. 1996 Oct;49(10):798-801 PubMed
Drug Resist Updat. 2011 Jun;14(3):164-76 PubMed
J Clin Microbiol. 2009 Apr;47(4):1063-73 PubMed
Clin Infect Dis. 2008 Jun 15;46(12):1813-21 PubMed
J Clin Microbiol. 2012 Jan;50(1):7-15 PubMed
Clin Microbiol Infect. 2010 Sep;16(9):1328-34 PubMed
Am J Med Sci. 2010 Sep;340(3):253-7 PubMed